The disc is a visceolastic one-piece, next generation total disc replacement featuring a polymer core, designed to restore function of the spine and reduce pain and disability. The company is able to commercially distribute the disc in Europe and will purse the FDA IDE approval in the United States in the future.
More Articles on Orthopedic Devices:
TransCorp Spine Names Christopher Welch President & CEO
6 New Spine Device Company Financial Reports
Orthofix Completes Sale of Sports Medicine Business
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
